ABSTRACT
INTRODUCTION
Congestive cardiac failure (CCF) or heart failure (HF) is a structural or functional ventricular disorder that impairs the fi lling or ejection of blood [Hunt 2005 ], which leads to decreased blood supply to the body, fl uid retention, and congestion. This condition has a gross impact on the quality of life and the survival prospects of the affected individuals. Over the past 2 decades, the number of patients dying of CCF has doubled, increasing the burden on the health care system and society [Koelling 2004] . CCF is a progressive disorder and may cause irreversible structural damages.
CCF is mainly a chronic condition and can be caused by ischemic heart disease (IHD), hypertension, idiopathic cardiomyopathy, and valvular heart disease [Hunt 2005] . It can present acutely in certain circumstances, such as myocardial infarction (MI) (with or without structural cardiac damage) and infective endocarditis, and produce acute decompensated HF (ADHF), resulting in signs and symptoms of HF and almost always leads to pulmonary or systemic congestion [Gheorghiade 2005] .
ADHF is an indication for hospital admission and is usually treated with diuretics, vasodilators, and inotropes. The mortality rate reported for these patients after discharge has been as high as 20% [Solomon 2007 ]. Acute cardiovascular dysfunction has been reported to occur perioperatively in more than 20% of patients undergoing cardiac surgery [Koerner 2001] . Several studies have shown that cardiac surgery can be of great benefi t for patients with CCF, especially if the cause is IHD [CASS 1983; Kaul 1996; Elefteriades 1997; Benetis 2005] , and the postoperative mortality rate is reduced signifi cantly with adequate myocardial protection and complete revascularization. Therefore, the benefi ts of a surgical approach over medical therapy have been demonstrated for CCF. The main question, however, relates to the optimal timing for surgery, especially in patients with ADHF. The general consensus is usually to wait until after the acute phase, because cardiac surgery in these patients carries a signifi cant risk Th e Heart Surgery Forum #2010-1137 14 (3), 2011 [Epub June 2011 ] doi: 10.1532 of morbidity and mortality. Therefore, except for emergencies and in unstable cases, the recommendation has been for cardiac surgery to be delayed until the patient has recovered from the acute episode.
The objective of this study was to determine the consequences of cardiac surgery in patients with current CCF and to compare their outcomes with the results of surgery for patients with a history of previous CCF.
MATERIALS AND METHODS

Patient Population
In this retrospective study, we reviewed prospectively collected patient data for our institution during the 10-year period between 1999 and 2009. We included 2285 patients with a history of HF, past or present, who were to undergo cardiac surgery and divided them into 2 groups: group A (n = 704), patients who had ADHF at the time of cardiac surgery and had such symptoms as pulmonary edema, cardiogenic shock, or peripheral edema; and group B (n = 1581), patients who had a history of one or more episodes of ADHF but who had recovered from the acute phase. The patient details, the registry database, medical records, and the national death index were reviewed for both groups. Table 1 summarizes the patient characteristics. The median age was 68.5 years (25th-75h percentiles, 60.7-75.2 years) and 69.6 years (25th-75th percentiles, 62.5-75.2 years) in group A and group B, respectively. The logistic Euro-SCORE was signifi cantly higher in group A than in group B (P < .001).
Operations
Various procedures were analyzed in 6 different groups: (1) isolated coronary artery bypass grafting (CABG), (2) aortic valve replacement (AVR), with or without CABG; (3) mitral valve replacement or repair (MVR), with or without CABG; (4) AVR plus MVR, with or without CABG; (5) ventricular septal defect closure, with or without CABG; and (6) other cardiac procedures, such as excision of myxoma and atrial septal defect closure (Table 2 ). Procedures such as pulmonary embolectomy, insertion of epicardial leads, or tricuspid valve surgery were excluded.
Statistical Analysis
All statistical analyses were performed retrospectively with SAS for Windows (version 8.2; SAS Institute, Cary, NC, USA). Continuous variables not normally distributed are presented as the median with the 25th and 75th percentiles. Categorical data are presented as percentages. Univariate comparisons were made with the Wilcoxon rank sum test and the chi-square test as appropriate. Deaths occurring over time were described with Kaplan-Meier survival curves [Kaplan 1958 ]. 
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To account for differences in the case mix, we developed a propensity score for HF group membership [Blackstone 2002 ]. We used multivariable logistic regression analysis [Hosmer 1989 ] to determine the propensity for membership in the ADHF group (group A) without regard to outcome. We developed a full nonparsimonious model that included all of the variables listed in Tables 1 and 2 . The goal was to balance patient preoperative and operative characteristics by incorporating everything recorded that could relate to either systematic bias or simply bad luck. This model yielded a C statistic of 0.71, indicating an acceptable ability to differentiate between patients with or without ventricular dysfunction. We then used a macro (available at http:// www2.sas.com/proceedings/sugi29/165-29.pdf) to perform propensity matching. After propensity matching, the outcomes of the 290 cases remaining in each group were compared. In all cases, a P value <.05 was considered statistically signifi cant.
RESULTS
Operations
Prior to the matching for the preoperative and operative characteristics, there were signifi cant differences between the 2 groups in the types of the operations. More isolated CABG procedures and procedures of MVR with or without CABG were performed in patients with previous CCF, whereas procedures consisting AVR with or without CABG were more common in the ADHF patients than in the patients who had previous CCF. Nonelective cases constituted 59.5% of the patients in group A (with acute CCF), compared with the 17.1% in group B (P < .001). The frequency of redo procedures in the ADHF group (11.5%) was also higher than in the group with previous CCF (7.3%). In addition, preoperative use of an intra-aortic balloon pump (IABP) was signifi cantly higher in the ADHF group (14.9%) than in the patients with previous CCF (1.1%). The type of procedure, nonelective cases, and redo operations were also taken into consideration for propensity matching. Postoperative LOS, d 10 (7-19) 9 (7-13) <.001 10 (7-17) 9 (7-14)
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In-hospital mortality, % 15.5 5.9 <.001 12.4 8.6 .14 *Continuous data are presented as the median (25th-75th percentiles) and analyzed with the Wilcoxon rank sum test. Categorical data are presented as percentages and analyzed with the chi-square test. CCF indicates congestive cardiac failure; CABG, coronary artery bypass grafting; AVR, aortic valve replacement; MVR, mitral valve replacement or repair; VSD, ventricular septal defect; IABP, intra-aortic balloon pump; ICU, intensive care unit; LOS, length of stay.
Postoperative Course
Prior to adjustment for preoperative and operative characteristics, the percentage of patients requiring postoperative inotropic support and IABP use was signifi cantly higher in group A (70.7% and 9.5%, respectively) than in group B (54.6% and 4.8%). Ventilation times, intensive care unit, and hospital stays were all signifi cantly higher in the ADHF group than in the group with previous CCF (P < .001). Furthermore, the rate of reexploration for bleeding was signifi cantly higher in the ADHF group (group A) than in group B (8% versus 5.4%); however, the 2 groups were not different with respect to the amount of blood loss through the mediastinal and pleural drains. This fi nding suggests a lower threshold for reexploration in group A compared with group B (P = .02).
After adjusting for the preoperative and operative characteristics, we observed no difference between the 2 groups in inotrope and IABP requirements or in the rate of reexploration. Ventilation time was prolonged in group A compared with group B, but the difference did not reach statistical signifi cance. The 2 groups were also similar with respect to the lengths of intensive care unit and hospital stays.
Postoperative Complications
Compared with group B, group A had signifi cantly higher rates of complications such as renal failure (18.9% versus 11.3%), postoperative arrhythmia (30.7% versus 25.4%), and MI (3% versus 1.1%) (P values <.05). On the other hand, groups A and B showed no statistically signifi cant differences in the incidence of stroke (4.7% versus 3.2%) and surgical wound infection (5% versus 4.1%). After adjustment of groups A and B for the preoperative characteristics, both groups had similar rates of complications, except for the signifi cantly higher incidence of MI in group A (4.4% versus 0.7%; see Table 2 ).
In-Hospital Mortality
In-hospital mortality was signifi cantly higher in acute cases (group A) than in group B (15.5% versus 5.9%); however, after adjustment for preoperative and operative characteristics, no difference between the 2 groups was identifi ed (P = .14).
Early, Medium-term, and Long-term Survival Rates
Before adjustment for preoperative characteristics, early (30-day), medium-term (5-year) and long-term (10 year) survival rates were signifi cantly lower in the patients with ADHF. After matching for the preoperative and operative characteristics, however, the 2 groups showed no difference in survival rate (Table 3) .
DISCUSSION
CCF is mainly a chronic condition. Different causes have been identifi ed for the development of CCF. It can be due to infection (cardiomyopathy/myocarditis/endocarditis), it can be due to structural/chronic cardiac disease, or it can be idiopathic. Some patients also present with symptoms related to acute HF for which there is a surgically reversible cause, such as MI, infective endocarditis, and valvular heart disease. Surgery is usually postponed or delayed for patients with ADHF, either because of late cardiologic referral or because the cardiac surgeons have postponed surgery. In many cases, the general belief is that cardiac surgery in the acute stage can increase the incidence of postoperative complications and mortality. Therefore, except in cases of emergencies and salvage procedures, heart surgery is delayed until the patient has recovered from the acute episode. After treating such patients conservatively, however, the reported mortality rate prior to surgery is still as high as 20% [Solomon 2007] .
It is important to identify whether CCF is the result or the cause of any cardiac pathology, such as IHD, aortic valve disease, or mitral valve disease. If CCF is due to such conditions as aortic stenosis, mitral regurgitation, and IHD, an early operation can reverse the structural and ongoing damage to the cardiac muscle. On the other hand, cardiac failure that is due to an organic or structural cardiac muscle problem can produce such conditions as aortic valve insuffi ciency or mitral valve regurgitation, which can subsequently start a vicious cycle that exacerbates the CCF. In these circumstances, an operation can prevent further deterioration of HF. Several studies have shown that cardiac surgery has great benefi t in patients with CCF, especially if the cause is IHD [CASS 1983; Kaul 1996; Elefteriades 1997; Benetis 2005] . The timing of such surgery remains unclear, however. Furthermore, despite the superiority of surgery to medical therapy, some authors have shown a decreased benefi t for CABG soon after an acute MI [Lee 2001 ]; however, most of these authors did not specify the percentage of patients who had ADHF due to acute MI at the time of surgery.
In this report we have shown that patients in ADHF do have a higher incidence of postoperative mortality and a demonstrated worse outcome compared with patients who had experienced a previous event. When we matched these Th e Heart Surgery Forum #2010-1137
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groups for their preoperative and operative characteristics, however, the 2 groups did not differ with respect to surgical outcome and even survival rate. These fi ndings indicate that ADHF is not a contraindication to cardiac surgery. When such patients are reviewed, their overall risk factors and preoperative comorbidities should be taken into consideration before deciding to proceed or delay surgical intervention. This recommendation does not mean that patients who have had a recent acute MI and are in HF are always suitable candidates for surgery, but postponing surgical intervention may not be desirable either. Indeed, a delay can lead to deterioration that produces a higher incidence of postoperative complications and mortality.
The main limitation of this study is its retrospective nature. More importantly, the diagnosis of HF, which was made by the cardiologist, the surgeon, and the anesthetist, was based on clinical and echocardiographic fi ndings. In addition, the exact interval between a previous event and performing cardiac surgery was not taken into consideration; therefore, this study does not allow us to comment on the optimal time of surgery after an event. It does, however, demonstrate that ADHF patients may not have a worse outcome than patients who have recovered from an ADHF. Identifying the optimal timing of surgery for patients with present or previous ADHF requires randomized controlled trials.
We conclude that individual preoperative assessment of patients with risk stratifi cation remains the most important factor in justifying the optimal timing of surgical intervention after a current or previous episode of HF. In other words, our results suggest that ADHF per se is not a contraindication to cardiac surgery.
